Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
HIV Medicine|January 25, 2017
HIV continuum of care in Europe and Central AsiaR S Drew, B Rice, K Rüütel, et al.The European Respiratory Journal|July 2, 2011
The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and resultsM E Kruijshaar, L Pimpin, I Abubakar, et al.HIV Medicine|August 2, 2016
Recent trends and patterns in HIV-1 transmitted drug resistance in the United KingdomA Tostevin, E White, D Dunn, et al.HIV Medicine|April 30, 2019
HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introductionK J Ong, A J van Hoek, R J Harris, et al.Sexually Transmitted Infections|July 1, 2009
Trends in HIV testing and recording of HIV status in the UK primary care setting: a retrospective cohort study 1995-2005H E R Evans, C H Mercer, G Rait, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 17, 2009
Molecular epidemiology of tuberculosis in England, 1998J Love, P Sonnenberg, J R Glynn, et al.Sexually Transmitted Infections|October 27, 2009
Primary care consultations and costs among HIV-positive individuals in UK primary care 1995-2005: a cohort studyH E R Evans, A Tsourapas, C H Mercer, et al.HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.HIV Medicine|November 21, 2008
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapyC A Sabin, C J Smith, V Delpech, et al.HIV Medicine|February 12, 2010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populationsL Bansi, C Sabin, V Delpech, et al.Pageof 6